Download Free Sample Report

The global Anti Peptic Ulcer Drugs market was valued at US$ 8965.2 million in 2022 and is projected to reach US$ 20860 million by 2029, at a CAGR of 12.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
This report aims to provide a comprehensive presentation of the global market for Anti Peptic Ulcer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti Peptic Ulcer Drugs. This report contains market size and forecasts of Anti Peptic Ulcer Drugs in global, including the following market information:

• Global Anti Peptic Ulcer Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
• Global Anti Peptic Ulcer Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
• Global top five Anti Peptic Ulcer Drugs companies in 2022 (%)

Global Anti-Peptic Ulcer Drugs key players include AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, etc. Global top five players hold a share about 50%.
In terms of product, the segment includes Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs. And in terms of application, the application includes Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD).
We surveyed the Anti Peptic Ulcer Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti Peptic Ulcer Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti Peptic Ulcer Drugs Market Segment Percentages, by Type, 2022 (%)

• Proton Pump Inhibitors (PPIs)
• Potassium-Competitive Acid Blockers (P-CAB)
• Antacids
• H2 Antagonists
• Antibiotics
• Ulcer Protective Drugs

Global Anti Peptic Ulcer Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti Peptic Ulcer Drugs Market Segment Percentages, by Application, 2022 (%)

• Gastritis
• Gastric Ulcers
• Duodenal Ulcers
• Gastroesophageal Reflux Disease (GERD)

Global Anti Peptic Ulcer Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti Peptic Ulcer Drugs Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti Peptic Ulcer Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti Peptic Ulcer Drugs revenues share in global market, 2022 (%)
Key companies Anti Peptic Ulcer Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti Peptic Ulcer Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Eisai
• Daewoong Pharmaceutical
• Takeda Pharmaceutical
• HeliCure
• AstraZeneca
• Ore Holdings
• Sihuan Pharmaceutical
• GlaxoSmithKline
• Pfizer
• Abbott Laboratories
• Yuhan Corporation
• Cadila Healthcare
• Boehringer Ingelheim

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Anti Peptic Ulcer Drugs, market overview.
• Chapter 2: Global Anti Peptic Ulcer Drugs market size in revenue and volume.
• Chapter 3: Detailed analysis of Anti Peptic Ulcer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Anti Peptic Ulcer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: Global Anti Peptic Ulcer Drugs capacity by region & country.
• Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
• Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
• Chapter 11: The main points and conclusions of the report.